1 | IXEKIZUMAB (Taltz (TN)) | 1件: Ixekizumab Ixekizumab (Taltz) | 1件: Ixekizumab
Ixekizumab
(Taltz (TN)) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 36 36, 37, 46, 107, 160, 162, 269, 271 💬
|
2 | Taltz | 1件: Ixekizumab Ixekizumab (Taltz) | 1件: Ixekizumab
Ixekizumab
(Taltz (TN)) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 36 36, 107, 271 💬
|
3 | Taltz (80 mg solution for injection in pre-filled syringe) | 1件: Ixekizumab Ixekizumab (Taltz) | 1件: Ixekizumab
Ixekizumab
(Taltz (TN)) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 2件: 107 107, 271 💬
|
4 | Taltz 80mg | 1件: Ixekizumab Ixekizumab (Taltz) | 1件: Ixekizumab
Ixekizumab
(Taltz (TN)) 💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 36 36 💬
|